Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › brodalumab

brodalumab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of brodalumab

6 trials tracked of brodalumab: 2 in phase 3 or 4.

6Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 2 2 Phase 1 2
  1. Phase 4 Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies Completed
  2. Phase 4 A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis Completed
  3. Phase 2 Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis Completed
  4. Phase 2 Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate Completed
  5. Phase 1 Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects Completed
  6. Phase 1 A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Brodalumab Improves Palmoplantar Pustulosis in Japanese Adults in Phase 3 Trial
Dermatology RCT
Brodalumab Improves Palmoplantar Pustulosis in Japanese Adults in Phase 3 Trial Brodalumab shows benefit for palmoplantar pustulosis in Japanese adults
This randomized Phase 3 trial in Japanese adults with palmoplantar pustulosis found that brodalumab 210 mg improved PPPASI scores similarly …
A Phase 3 trial found brodalumab improved skin scores for palmoplantar pustulosis in Japanese adults, though infection risks were frequent.
May 1, 2026